# Effects of Resveratrol in Patients With Type 2 Diabetes

> **NCT01677611** · PHASE1 · COMPLETED · sponsor: **Khoo Teck Puat Hospital** · enrollment: 10 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Trans-resveratrol extract from Polygonum Cuspidatum
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01677611
- **Lead sponsor:** Khoo Teck Puat Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-09
- **Final completion:** 2012-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677611, "Effects of Resveratrol in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01677611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*